Achilles Therapeutics is a startup based in the United Kingdom, most recent round Series-c-plus, 2 tracked investors.
Achilles Therapeutics is a company founded in 2015 headquartered in the United Kingdom. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Achilles Therapeutics is a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal neoantigens to treat solid tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.